Highest-materiality recent filing
Thomas Sweeney resigned as CFO effective Oct 29, 2025, to pursue other opportunities; no disagreement with Board or management.
Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as independent director
Appointed Oct 17, 2025 as Class II director on audit, nominating, and compensation committees; deemed independent under Nasdaq and Rule 10A-3.
Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO
Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.
John Frank resigned from the board effective Jan 6, 2025, not due to any disagreement with the company.
Oaktree Acquisition Corp. III Life Sciences units to separate into shares and warrants Dec 16
Holders may elect to separate units into Class A ordinary shares and warrants starting December 16, 2024.
Oaktree Acquisition Corp. III Life Sciences closes partial over-allotment, trust grows to $192M
Underwriters purchased 1,699,029 additional units at $10.00 each, generating $16.99M gross proceeds.
Completed IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
Oaktree Acquisition Corp. III Life Sciences prices $175M IPO at $10/unit
Gross proceeds of $175M from 17.5M units at $10.00 each; units trade on Nasdaq as OACCU.
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
On January 6, 2025, John Frank resigned from the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”).
the Board appointed (i) Aman Kumar, currently a director of the Company, as the new chairman of the Board
and (ii) Zaid Pardesi, the Company’s Chief Executive Officer, as a director of the Company.
Max materiality 0.70 · Median 0.50 · Most common event leadership